Skip to main content
Premium Trial:

Request an Annual Quote

Worth the Hassle?

Recently implemented disclosure rules at the US National Institutes of Health may not be living up to expectations, Nature News reports.

The agency put new conflict-of-interest rules into place in 2012 following a 2008 Senate investigation that found that Charles Nemeroff, an Emory University psychiatrist, had failed to disclose some $1.2 million in income from drug companies. The new rules require researchers to report whether they've received more than $5,000 from any outside source, to provide greater detail about any relationships with industry, including sponsored travel, and to disclose relationships with nonprofits. The researchers' institutions then determine which relationships may be problematic.

But Nature News reports that institutions use varying thresholds to make those judgments, and many universities say that the cost of implementing the new rules hasn't been balanced by the discovery of new conflicts of interest.

For instance, Yale University's Andrew Rudczynski says the school spent $500,000 to put the new COI rules in place. The following year, researchers there doubled the number of disclosures they made, but the school only uncovered one new conflict.

Paul Thacker, who led the Senate investigation as a member Senator Charles Grassley's staff, tells Nature News that it is unclear whether the new rules are working, but argues that greater scrutiny is needed.

Nature News adds that NIH plans to review these COI reforms later this year.

The Scan

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.

New Oral Nanomedicine Strategy Targets Gut-Brain Axis to Treat IBD

A new paper in Science Advances describes a platform to design polyphenol-armored oral medicines that are effective at treating inflammatory bowel disease.

Phylogenetic Data Enables New Floristic Map

Researchers in Nature Communications use angiosperm phylogenetic data to refine the floristic regions of the world.

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.